Clinical pathological characteristics and prognosis of orbital myeloid sarcoma-a single center retrospective study with 14 Chinese patients

Abstract Purpose Myeloid sarcoma (MS) is a rare extramedullary tumor of myeloid origin, often underdiagnosed or misdiagnosed, particularly in children. This study aims to evaluate the clinicopathological features, immunophenotypes, therapeutic approaches, and prognosis to enhance patient management....

Full description

Saved in:
Bibliographic Details
Main Authors: Tianyi Zhou, Jiaqi Guan, Huijing Ye, Huasheng Yang
Format: Article
Language:English
Published: Springer 2025-01-01
Series:Holistic Integrative Oncology
Subjects:
Online Access:https://doi.org/10.1007/s44178-024-00144-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544183119085568
author Tianyi Zhou
Jiaqi Guan
Huijing Ye
Huasheng Yang
author_facet Tianyi Zhou
Jiaqi Guan
Huijing Ye
Huasheng Yang
author_sort Tianyi Zhou
collection DOAJ
description Abstract Purpose Myeloid sarcoma (MS) is a rare extramedullary tumor of myeloid origin, often underdiagnosed or misdiagnosed, particularly in children. This study aims to evaluate the clinicopathological features, immunophenotypes, therapeutic approaches, and prognosis to enhance patient management. Methods This retrospective, single-center case series examined 14 patients diagnosed with myeloid sarcoma through pathological analysis. Results The median age at diagnosis was 7 years, with a male-to-female ratio of 8:6. The median disease duration at diagnosis was 1 month, and all patients had unilateral eye involvement. The most common presentation was proptosis, followed by restricted eye movement and eyelid swelling. Immunohistochemical analysis revealed that MPO (myeloperoxidase) and lysozyme were the most frequently expressed markers, followed by CD56, α1-antitrypsin (AACT), and CD34. Eleven patients were treated with chemotherapy according to the acute myeloid leukemia (AML) regimen. The median follow-up time for these patients was 13 months. No relapses occurred; one patient died, and three were lost to follow-up. The Kaplan–Meier survival analysis estimated a 5-year overall survival (OS) and event-free survival (EFS) rate of 87.5%. Conclusion Diagnosing myeloid sarcoma (MS) is often challenging. An adequate tumor biopsy and comprehensive immunohistochemical analysis are essential for an accurate diagnosis. Early and consistent systemic chemotherapy can result in long-term survival.
format Article
id doaj-art-0ca1e897773e4ac0993b559789dfef8a
institution Kabale University
issn 2731-4529
language English
publishDate 2025-01-01
publisher Springer
record_format Article
series Holistic Integrative Oncology
spelling doaj-art-0ca1e897773e4ac0993b559789dfef8a2025-01-12T12:44:16ZengSpringerHolistic Integrative Oncology2731-45292025-01-014111010.1007/s44178-024-00144-2Clinical pathological characteristics and prognosis of orbital myeloid sarcoma-a single center retrospective study with 14 Chinese patientsTianyi Zhou0Jiaqi Guan1Huijing Ye2Huasheng Yang3State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University,Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular DiseasesState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University,Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular DiseasesState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University,Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular DiseasesState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University,Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular DiseasesAbstract Purpose Myeloid sarcoma (MS) is a rare extramedullary tumor of myeloid origin, often underdiagnosed or misdiagnosed, particularly in children. This study aims to evaluate the clinicopathological features, immunophenotypes, therapeutic approaches, and prognosis to enhance patient management. Methods This retrospective, single-center case series examined 14 patients diagnosed with myeloid sarcoma through pathological analysis. Results The median age at diagnosis was 7 years, with a male-to-female ratio of 8:6. The median disease duration at diagnosis was 1 month, and all patients had unilateral eye involvement. The most common presentation was proptosis, followed by restricted eye movement and eyelid swelling. Immunohistochemical analysis revealed that MPO (myeloperoxidase) and lysozyme were the most frequently expressed markers, followed by CD56, α1-antitrypsin (AACT), and CD34. Eleven patients were treated with chemotherapy according to the acute myeloid leukemia (AML) regimen. The median follow-up time for these patients was 13 months. No relapses occurred; one patient died, and three were lost to follow-up. The Kaplan–Meier survival analysis estimated a 5-year overall survival (OS) and event-free survival (EFS) rate of 87.5%. Conclusion Diagnosing myeloid sarcoma (MS) is often challenging. An adequate tumor biopsy and comprehensive immunohistochemical analysis are essential for an accurate diagnosis. Early and consistent systemic chemotherapy can result in long-term survival.https://doi.org/10.1007/s44178-024-00144-2Myeloid sarcomaAcute myeloid leukemiaPrognosisKI-67
spellingShingle Tianyi Zhou
Jiaqi Guan
Huijing Ye
Huasheng Yang
Clinical pathological characteristics and prognosis of orbital myeloid sarcoma-a single center retrospective study with 14 Chinese patients
Holistic Integrative Oncology
Myeloid sarcoma
Acute myeloid leukemia
Prognosis
KI-67
title Clinical pathological characteristics and prognosis of orbital myeloid sarcoma-a single center retrospective study with 14 Chinese patients
title_full Clinical pathological characteristics and prognosis of orbital myeloid sarcoma-a single center retrospective study with 14 Chinese patients
title_fullStr Clinical pathological characteristics and prognosis of orbital myeloid sarcoma-a single center retrospective study with 14 Chinese patients
title_full_unstemmed Clinical pathological characteristics and prognosis of orbital myeloid sarcoma-a single center retrospective study with 14 Chinese patients
title_short Clinical pathological characteristics and prognosis of orbital myeloid sarcoma-a single center retrospective study with 14 Chinese patients
title_sort clinical pathological characteristics and prognosis of orbital myeloid sarcoma a single center retrospective study with 14 chinese patients
topic Myeloid sarcoma
Acute myeloid leukemia
Prognosis
KI-67
url https://doi.org/10.1007/s44178-024-00144-2
work_keys_str_mv AT tianyizhou clinicalpathologicalcharacteristicsandprognosisoforbitalmyeloidsarcomaasinglecenterretrospectivestudywith14chinesepatients
AT jiaqiguan clinicalpathologicalcharacteristicsandprognosisoforbitalmyeloidsarcomaasinglecenterretrospectivestudywith14chinesepatients
AT huijingye clinicalpathologicalcharacteristicsandprognosisoforbitalmyeloidsarcomaasinglecenterretrospectivestudywith14chinesepatients
AT huashengyang clinicalpathologicalcharacteristicsandprognosisoforbitalmyeloidsarcomaasinglecenterretrospectivestudywith14chinesepatients